By Sabela Ojea
Anew Health filed for an initial public offering with the Securities and Exchange Commission.
The medication-management and pharmacy-care provider on Friday said that it would issue 5 million ordinary shares at a price of $4 a share.
The company said it planned to list its shares on the Nasdaq Global Market under the symbol AVG.
The company expects to receive net proceeds from the offering of around $16.4 million, with around 30% of it planned for establishing a new treatment center in Hong Kong.
Anew Health reported revenue of $40.8 million for the fiscal year ended March 31, 2024, from $27.3 million for the same period a year earlier.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
March 07, 2025 18:06 ET (23:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.